Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa

This article discusses the high potential of the RTS,S vaccine for malaria in children. Additionally, results show that not only will the vaccine likely lead to positive health outcomes, but it is expected to do so in a cost-effective manner.

← Back to previous page